|Bid||0.3650 x 0|
|Ask||0.3750 x 0|
|Day's Range||0.3650 - 0.3900|
|52 Week Range||0.2000 - 0.6600|
|Beta (3Y Monthly)||2.03|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 19, 2019 - Aug 23, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.94|
OTCQX: EEVVF) is thrilled to announce that it has completed construction of its 780,000 square foot hybrid greenhouse expansion located in Southwestern Ontario. The expansion is situated on the same property as the Company’s currently 220,000 square foot licensed hybrid greenhouse.
OTCQX: EEVVF) is pleased to announce Health Canada’s approval of two additional drying rooms. Additionally, the new rooms are designed to maximize throughput, leveraging new designs to allow more plants at one time than the Company’s existing drying rooms. “We are very pleased to have received Health Canada’s approval for our two new drying rooms, as we continue to ramp up production.
It hasn't been the best quarter for Eve & Co Incorporated (CVE:EVE) shareholders, since the share price has fallen 26...
OTCQX: EEVVF) is pleased to announce the launch of its cannabis in dried flower format at select Newfoundland licensed cannabis retailers and on the Cannabis Newfoundland website on June 28, 2019. Launching our dried cannabis flower in Newfoundland will be the natural next step for our brand. Cannabis Newfoundland has been a pleasure to work with and a wonderful partner in bringing our products to their province,” said Amanda Jasevicius, Manager of Domestic Sales for the Company.
OTCQX: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that its common shares will be listed for trading on the OTCQX Best Market in the United States under the symbol EEVVF effective June 21, 2019. Eve & Co upgraded to OTCQX from the OTCQB Venture Market. The Company’s shares will also continue to trade on the TSX Venture Exchange under the symbol EVE.
OTCQB: EEVVF) is pleased to announce that Ivan Ross Vrána has been appointed as a Vice President and will be responsible for leading the Company's government relation efforts and assisting with business development. Ivan Ross Vrána has a wealth of experience in the cannabis industry.
OTCQB: EEVVF) is pleased to announce that its wholly-owned subsidiary Natural MedCo Ltd. has entered into a second binding non-exclusive supply agreement for the sale of dried cannabis to a German importer and distributor. The supply agreement is for an initial term of three years and is automatically renewable for two subsequent two-year terms unless otherwise terminated by the parties at the end of the initial or renewal term. The German distributor has agreed to purchase 500 kilograms of dried cannabis per month for the first two months and a minimum of 1,000 kilograms and a maximum of 5,000 kilograms per month for the next 22 months. The Company expects to commence shipments subsequent to the anticipated Q2 2019 completion of its 780,000 square foot greenhouse expansion, and the anticipated subsequent approval thereof by Health Canada.
The financial statements and management discussion and analysis for such interim period are available on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on Eve & Co's website at www.evecannabis.ca.
Each Special Warrant will be exercisable into one (1) unit of the Company (a “Unit”), for no additional consideration at any time and each Special Warrant not previously exercised shall be deemed exercised on the earlier of (i) the fifth business day after a receipt is issued for a final prospectus qualifying the Units for distribution in all of the Canadian provinces in which purchasers reside (the “Qualifying Jurisdictions”) and (ii) September 11, 2019. Each Unit consists of one (1) common share of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one Common Share (a “Warrant Share”) at an exercise price of $0.60 at any time up May 10, 2021.
OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to report the filing of its audited financial results for the fourteen month period ended December 31, 2018. A copy of the audited consolidated financial statements (the “Financial Statements”) for the fourteen months ended December 31, 2018 prepared in accordance with International Financial Reporting Standards and the corresponding management’s discussion and analysis for this period will be available under the Company’s profile on “SEDAR” at www.sedar.com and on Eve & Co’s website at www.evecannabis.ca. In connection with the Company’s qualifying transaction which closed on June 28, 2018, the Company changed its year-end from October 31 to December 31.
TORONTO, April 23, 2019 -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce it will report financial results for.
OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that Alice Murphy has been appointed to its Board of Directors. Ms. Murphy has a wealth of financial experience with public companies at a senior level. As the former CFO of Harry Winston Diamond Corporation, she had responsibility for overseeing the financial reporting of its global entities, its compliance with NYSE listing requirements and the financial due diligence of its global M&A activities. Ms. Murphy has gained valuable experience with Health Canada from her role as CFO of a First Nations community, where she helped coordinate the financial and risk analysis of a medical marijuana application.
TORONTO, April 18, 2019 -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQB: EEVVF) is pleased to announce that 16,665,000 of its June 2018 common.
OTCQB: EEVVF) is pleased to announce that it has entered into an engagement letter with Haywood Securities Inc. (the “Underwriter”) pursuant to which the Underwriter has agreed to purchase 20,000,000 special warrants of the Company (the “Special Warrants”), on a bought deal basis, at a price of $0.50 per Special Warrant for aggregate gross proceeds of $10 million (the “Offering”). Each Special Warrant will be exercisable into one (1) unit of the Company (a “Unit”), for no additional consideration, at any time after the Closing, and each Special Warrant not previously exercised shall be deemed exercised on the later of (i) the fifth business day after a receipt is issued for a final prospectus qualifying the Units for distribution in all of the Canadian provinces, except Quebec (the “Qualifying Jurisdictions”) and (ii) the date that is four months and one day following the Closing.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Eve & Co Incorporated's (CVE:EVE): Eve & Co Incorporated, through its subsidiary, Natural MedCo Ltd., produces and sell...
OTCQB: EEVVF) is pleased to announce that the remaining $4,000,000 principal amount of senior unsecured convertible debentures of the initial $10,000,000 principal amount of debentures issued by the Company in June 2018 has now been converted into common shares of the Company. A total of 13,333,333 common shares in the capital of the Company have been issued to the holder of such debentures in accordance with the terms of the debentures. This conversion strengthens our balance sheet and provides us with the flexibility to prioritize resource allocation to operating activities as the Company makes headway on its business development efforts and Phase 2 expansion project.” stated Melinda Rombouts, CEO of Eve & Co.
OTCQB: EEVVF) is pleased to announce that Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd. (“NMC”), has entered into an $18,700,000 construction facility with Royal Bank of Canada (the “Lender”) to fund the completion of the 780,000 sq. ft. expansion of its greenhouse production facility located in Middlesex County, Ontario. After completion of the expansion which is expected by the end of Q2 2019, it is contemplated that the construction facility will be replaced with a non-revolving term facility. Interest on the facilities will float at a rate of 1.00% per annum above the Lender’s prime lending rate, which currently is 3.95% per annum. The obligations under the facilities will be guaranteed by Eve & Co and will be primarily secured by a collateral mortgage on NMC’s property located in Middlesex County. The facilities are subject to certain customary financial and other covenants for a financing of this type and advances under the facilities are subject to certain customary conditions precedent.
TORONTO, Feb. 11, 2019 -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that a product line of pre-rolls is now.
OTCQB: EEVVF) is pleased to announce that its wholly-owned subsidiary Natural MedCo Ltd. has entered into a binding non-exclusive supply agreement for the sale of dried cannabis to an established German importer and distributor of parapharmaceutical and medicinal products. The supply agreement is for an initial term of three years and is automatically renewable for two subsequent two-year terms unless otherwise terminated by the parties at the end of the initial or renewal term. The German distributor has agreed to purchase a minimum of 2,250 kilograms of dried cannabis over the initial two year period and can increase the amount ordered on the acceptance by Eve & Co. The parties expect the first shipments to commence in Q1 2019. “This agreement is an important milestone for us in our expansion into international markets. We are very pleased to be working with an established and reputable firm to access the German market where pricing continues to be at a substantial premium to local markets. We are excited to continue to develop opportunities for Natural MedCo and the EVE brand across multiple global markets," said Melinda Rombouts, President and Chief Executive Officer of Eve & Co.
OTCQB: EEVVF) is pleased to announce that Shari Mogk-Edwards has been appointed to its board of directors. Ms. Mogk-Edwards’ previous career spans over 35 years with one of the largest single buyers of beverage alcohol in the world – the Liquor Control Board of Ontario (the “LCBO”). As the Vice President, Products, Sales and Merchandising, she led a high performance team of 100 category and inventory specialists, and directed sales of over $5B. As a face of the LCBO, Shari managed her “Shari’s Picks” program, promoted responsible consumption, regularly represented the LCBO at trade, television and radio events, and was a key note speaker at countless events.
"Since receiving the amendment to our license to include additional sales on December 10th, 2018, we have initiated our first sales transactions and have completed delivery of approximately 162,000 grams of product. Further, the Company has filed its interim financial results for the three and twelve month periods ended October 31, 2018.The financial statements and management discussion and analysis for such interim period, are available on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on Eve & Co's website at www.evecannabis.ca. Additional Provincial Supply Arrangements – The Company entered into supply agreements with the Ontario Cannabis Retail Corporation and the Newfoundland and Labrador Liquor Corporation with respect to the supply of adult-use cannabis.
The Company believes it is uniquely positioned among its peers to offer a selection of clones given its management’s prior experience in the non-cannabis greenhouse industry and related production and sale of high-quality plants. Drawing on this experience, the Company will be using a unique solution for clone shipping and packaging to ensure its offerings are competitive. Eve & Co, through its wholly-owned subsidiary Natural MedCo Ltd., holds cultivation and processing licenses under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil.
TORONTO, Dec. 10, 2018 -- Eve & Co Incorporated (TSX-V: EVE; OTCQB: EEVVF) (“Eve & Co” or the “Company”) is pleased to announce that as of December 7, 2018, Health.